$Aeglea BioTherapeutics, Inc.(AGLE)$ 8-K - Current report Filed: 2018-05-08 AccNo: 0001564590-18-011483 Size: 236 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接